Benzinga's Top #PreMarket Gainers
January 08, 2014 at 08:12 AM EST
NuPathe (NASDAQ: PATH ) shares jumped 36.53% to $4.41 in pre-market trading after the company received an offer of $3.65 per share from Teva Pharmaceutical Industries (NYSE: TEVA ). Forest Laboratories (NYSE: FRX ) shares gained 13.71% to $66.81 in the pre-market after the company announced its plans
